BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2016
View Archived Issues
Bristol-Myers Squibb presents novel PAR-4 antagonists as promising antithrombotic agents
Read More
Cynata and FUJIFILM reach agreement to develop and commercialize regenerative medicine products
Read More
Cyr61 identified as a novel biomarker of coronary events
Read More
HP-3070 enters phase III clinical testing in the U.S. in patients with schizophrenia
Read More
Exeporfinium chloride demonstrates safety, tolerability and efficacy in U.S. clinical trial
Read More
OGD2 Pharma collaborates with Syndivia to develop ADCs targeting OAcGD2 antigen
Read More
FDA accepts for review CCP-07 NDA
Read More
TRx-237-007 phase III trial fails to achieve its coprimary endpoints
Read More
Cardiosphere-derived cell therapy shows benefit in single ventricle heart failure patients
Read More
Horizon Discovery collaborates with Fulcrum Therapeutics on CRISPR-based target discovery
Read More
Ciprofloxacin DPI shows efficacy in NCFB: first data from the RESPIRE 1 trial
Read More
New phase I trial tests Viaskin rPT to reactivate pertussis toxin immunity
Read More
European orphan drug designation for GLPG-1690 in IPF
Read More
Fresenius Helios to acquire Quironsalud
Read More
Biomarkers linked to excess reactive oxygen species identified in non-Hodgkin's lymphoma
Read More
Bayer in advanced negotiations with Monsanto
Read More
Latvian Institute of Organic Synthesis patents LeuRS inhibitors
Read More
NEONC Technologies patent reports agents for treatment of cancer
Read More
Lilly prepares and tests MetAP 2 and DPP IV inhibitors
Read More
Agents for RSV infections described in Aviragen Therapeutics patent
Read More
PCI Biotech updates progress of phase I/II bile duct cancer study
Read More
University of Southern California team reveals growth hormone receptor antagonists
Read More
131-I-8H9 monoclonal antibody granted FDA orphan drug designation in neuroblastoma
Read More
AbbVie's venetoclax granted new FDA orphan drug designation
Read More
FDA gives dabrafenib and trametinib orphan drug designation in thyroid cancer
Read More